Skip to main content

Probiotics in Irritable Bowel Syndrome (IBS): An update on Mode of Action & Efficacy

0.5 CPD learning hours

Probiotics in Irritable Bowel Syndrome (IBS): An update on Mode of Action & Efficacy

In this CPD accredited webinar, Professor Quigley delivers a summary of the role of the gut microbiota and probiotics in the management of the gastrointestinal and psychological symptoms of irritable bowel syndrome (IBS), including an exploration of the mode of actions and efficacy of specific strains. The latest research is discussed, with a focus upon Bifidobacterium longum 35624™ and Bifidobacterium longum 1714™ probiotic strains. The recording is from the PrecisionBiotics® Gastroenterology Summit held in London on 7th September 2023.

Learning Objectives:

  1. To understand the potential role of specific probiotic strains in the management of the symptoms of IBS
  2. To understand the clinical and real-world evidence base for specific probiotic strains in the management of IBS
  3. To understand the mode of action of specific probiotic strains, and how they interact with the gut-brain axis
  4. To understand the practical considerations for the use of probiotics in IBS including safety, long term use, viability and continuous versus intermittent use.

 

 

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.